AZRX Market Cap History



Below is a table of the AZRX market cap history going back to 10/11/2016:

Date AZRX Market Cap
10/11/201649.16M
11/22/201641.32M
3/31/201737.17M
5/12/201734.00M
8/14/201742.68M
11/13/201732.47M
3/15/201835.08M
4/25/201836.42M
5/14/201843.58M
8/10/201839.06M
11/9/201841.50M
4/1/201946.16M
4/29/201949.58M
5/15/201953.35M
8/12/201925.84M
7/31/201926.54M
11/14/201920.27M
3/30/202015.49M
4/27/202016.20M
5/14/202022.90M
8/12/202032.21M
11/13/202022.20M
3/29/202193.79M
5/18/202163.65M
8/13/202155.02M
9/13/202138.24M

Also see: AZRX Shares Outstanding History
and AZRX YTD Return
AZRX Historical Market Cap:
-4.97% CAGR
AZRX Historical Market Cap: +-4.97% CAGR

Mouse over chart for data details
10/11/2016 ...9/13/2021
AzurRx BioPharma is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. Co. is focused on developing its drug product candidate, MS1819, a yeast derived recombinant lipase for exocrine pancreatic insufficiency associated with cystic fibrosis and chronic pancreatitis. Co.'s b-lactamase program focuses on products with an enzymatic combination of bacterial origin for the prevention of hospital-acquired infections and antibiotic-associated diarrhea by resistant bacterial strains induced by parenteral administration of several antibiotic classes. Co.'s compounds in pre-clinical development include: AZX1101 and AZX1103. We show 26 historical shares outstanding datapoints in our AZRX shares outstanding history coverage, used to compute AZRX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AZRX market cap history over the course of time is important for investors interested in comparing AZRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AZRX versus a peer is one thing; comparing AZRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AZRX can fluctuate over the course of history. With this page we aim to empower investors researching AZRX by allowing them to research the AZRX market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree AZRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AzurRx BioPharma (AZRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AZYO Market Cap History
BACK Market Cap History
BASI Market Cap History
BAX Market Cap History
BBI Market Cap History
BBIO Market Cap History
BBLG Market Cap History
BCAB Market Cap History
BCDA Market Cap History
BCEL Market Cap History
More Healthcare companies »

 

AZRX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.